A RANDOMIZED, DOUBLE-BLIND, DOSE RESPONSE-CONTROL, CROSSOVER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TWO DOSES OF EUR-1008 (APT-1008) IN CHRONIC PANCREATITIS (CP) PARTICIPANTS WITH EXOCRINE PANCREATIC INSUFFICIENCY (EPI):